ARL
ARL · NSE · inactive
2.35
+0.10 (+4.44%)
as of 11 May 2012 close
Open
2.35
High
2.45
Low
2.25
Prev close
2.25
52w high
2.70
09 Jun 2011
52w low
1.80
15 Dec 2011
VWAP
2.34
Delivery %
79.5%
of volume
Volume 4.47 L · turnover ₹10.48 L · NSE bhavcopy (official close) · history since 08 Jan 2003
- Series
- EQ
- F&O
- No
- Status
- Inactive since 12 May 2012
Source: NSE equity master · as of 11 May 2012
Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 10:59 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
- 31 May 2006 24:00Business update
Arvind Remedies Limited has informed the Exchange that Arvind Remedies Limited has entered into agreement with Sri Ramachandra Medical College & Research Institute (Deemed University), Chennai and Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, for project in research and development of Ayurvedic Herbal Medicine for Rheumatoid Arthritis. The total project cost is estimated around Rs. 1.03 crore.
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries